DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Darexaban is an investigational drug.
There have been 9 clinical trials for Darexaban. The most recent clinical trial was a Phase 1 trial, which was initiated on January 1st 2010.
The most common disease condition in clinical trials is [disabled in preview]. The leading clinical trial sponsors are Astellas Pharma Inc, Astellas Pharma Europe B.V., and [disabled in preview].
Recent Clinical Trials for Darexaban
|To Evaluate if Multiple Doses of Ketoconazole Change the Blood Concentration of YM150 (Darexaban)||Astellas Pharma Inc||Phase 1|
|To Evaluate if Multiple Doses of Rifampicin Change the Blood Concentration of YM150 (Darexaban)||Astellas Pharma Inc||Phase 1|
|To Evaluate Whether Naproxen and Darexaban (YM150) Interact in Their Effects||Astellas Pharma Inc||Phase 1|